BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26802650)

  • 21. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
    Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
    J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma.
    Mu D; Huang R; Li S; Ma X; Lou C; Kuang A
    Cancer Gene Ther; 2012 Jun; 19(6):402-11. PubMed ID: 22498723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
    Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
    J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E; Unfer R; Vahanian N; Link C
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis.
    Pozo K; Hillmann A; Augustyn A; Plattner F; Hai T; Singh T; Ramezani S; Sun X; Pfragner R; Minna JD; Cote GJ; Chen H; Bibb JA; Nwariaku FE
    Oncotarget; 2015 May; 6(14):12080-93. PubMed ID: 25900242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.
    Smith VE; Sharma N; Watkins RJ; Read ML; Ryan GA; Kwan PP; Martin A; Watkinson JC; Boelaert K; Franklyn JA; McCabe CJ
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2876-86. PubMed ID: 23678037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation.
    Giardino E; Catalano R; Barbieri AM; Treppiedi D; Mangili F; Spada A; Arosio M; Mantovani G; Peverelli E
    Mol Cell Endocrinol; 2019 Sep; 495():110519. PubMed ID: 31352037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of BRD4 suppresses tumor growth and enhances iodine uptake in thyroid cancer.
    Gao X; Wu X; Zhang X; Hua W; Zhang Y; Maimaiti Y; Gao Z; Zhang Y
    Biochem Biophys Res Commun; 2016 Jan; 469(3):679-85. PubMed ID: 26707881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound.
    Meller J; Becker W
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S425-38. PubMed ID: 12192542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway.
    Sui X; Sui Y; Wang Y
    Mol Med Rep; 2018 Jun; 17(6):7521-7528. PubMed ID: 29620212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All-trans-retinoic acid promotes iodine uptake via up- regulating the sodium iodide symporter in medullary thyroid cancer stem cells.
    Tang M; Hou YL; Kang QQ; Chen XY; Duan LQ; Shu J; Li SL; Hu XL; Peng ZP
    Asian Pac J Cancer Prev; 2014; 15(4):1859-62. PubMed ID: 24641421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells.
    Bauriaud-Mallet M; Vija-Racaru L; Brillouet S; Mallinger A; de Medina P; Rives A; Payre B; Poirot M; Courbon F; Silvente-Poirot S
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105390. PubMed ID: 31170473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion.
    Giardino E; Catalano R; Mangili F; Barbieri AM; Treppiedi D; Elli FM; Dolci A; Contarino A; Spada A; Arosio M; Mantovani G; Peverelli E
    Mol Cell Endocrinol; 2021 Jan; 520():111092. PubMed ID: 33248230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors.
    Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
    Hum Gene Ther; 2006 Jun; 17(6):661-8. PubMed ID: 16776574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
    Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
    BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma.
    Yu C; Wu G; Dang N; Zhang W; Zhang R; Yan W; Zhao Y; Gao L; Wang Y; Beckwith N; Yuan J; Yao L
    Cancer Biol Ther; 2011 Aug; 12(4):304-13. PubMed ID: 21623166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.